Fibrocystic Breast Changes: Imaging and Pathological Correlational Study of a Sample in The Kurdistan Region of Iraq

Maysaloon Shaman  Saeed

doi:10.56056/amj.2024.295

Authors

Maysaloon Shaman Saeed FIBMS, PHD in Diagnostic Radiology, Consultant Radiologist, Assistant Professor, College of Medicine, University of Duhok

DOI:

https://doi.org/10.56056/amj.2024.295

Keywords:

Breast Imaging Reporting and Data System, Fibrocystic, Fine needle aspiration, Ultrasound

Abstract

Background and objectives: Fibrocystic changes of the breast are the most common breast changes observed globally. The study aimed to assess these changes using ultrasound and correlate the imaging findings with histopathological changes to determine accuracy.

Methods: A prospective cross-sectional study included 240 women who were diagnosed with fibrocystic breasts between January 2022 and July 2023 at a specialized medical center in Duhok city. Ultrasound was performed to evaluate changes in the breast. Imaging results were classified according to the guidelines of the American College of Radiology's Breast Imaging Reporting and Data System. Women with moderate imaging findings underwent ultrasound guided needle aspiration. The samples obtained were sent for cytological and histopathological evaluation. A correlation was conducted between the results of both of these modalities.

Results: The age group most affected was 29-49 years. Bilateral breast involvement was the most prevalent, accounting for 78% of the cases. 74% of the affected women complained of cyclical mastalgia. Ultrasound findings mainly show simple cysts, clustered cysts, and duct ectasia, accounting for 29%, 30%, and 15% respectively. BI-RAD 2, followed by 3, and then 4A were the most common imaging categories. Simple cyst (36%), ducts with apocrine metaplasia (23%), and epithelial hyperplasia without atypia (18%) were the most commonly observed histopathological findings. Statistically significant accuracy was observed regarding the imaging and cytological correlations in BI-RAD 3and 4A.

Conclusion: A strong correlation was observed between the ultrasound findings of breast fibrocystic changes and the histopathological evaluation.

Downloads

Download data is not yet available.

References

- Deva B, Vakamudia U, Thambiduraia L, Joseph L, Sirinivasan J. Imaging and Pathological Correlation in Spectrum of Fibrocystic Breast Disease and its Mimics – our Experience. Arch Breast Cancer. 2022; 9(4): 465-73.

- Sangma MB, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. J Clin Diagn Res. 2013;7(3):503-6.

- Kohnepoushi P, Dehghanbanadaki H, Mohammadzedeh P, Nikouei M, Moradi Y. The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis. Cancer Cell Int. 2022; 19;(1):125-33.

- Selvakumaran S, Sangma MB.Study of various benign breast diseases.Int Surg J2017;4(1):339-43.

- Samal S, Swain PK, Pattnayak S. Clinical, pathological and radiological correlative study of benign breast diseases in a tertiary care hospital. Int Surg J 2019;6(7):2428-32.

- Szep M, Chiorean A, Roman R, RogojanL, DumaM,Cluj N. et al. Imaging spectrum of breast focal fibrocystic changes: mammography, conventional ultrasound, Eur Radiol. https://dx.doi.org/10.1594/ecr2014/C-1237/

- Akreyi, H. The role of breast ultrasound in assessing patients with mastalgia in Erbil, Iraq. Zanco J Med Sci.2013, 17(1), 331-36.

- Spaka DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE. BI-RADS® fifth edition: A summary of changes. Diagn Interv Imaging. 2017;98(3):179-90.

- Hamawandi N. A prospective Study On Mastalgia in Sulaimania,Iraq. Bas S Surg 2010; 16(2): 46-54.

- Choe A, Kasales C, Mack J, Al-Nuaimi M, Karamchandani D. Fibrocystic Changes of the Breast: Radiologic–Pathologic Correlation of MRI, J. Breast Imaging. 2022; 4, (1): 48–55.

- Ghalib H, Ali D, Molah Karim S, Gubari M, Mohammed S, Marif D et al. Risk factors assessment of breast cancer among Iraqi Kurdish women: Case-control study J Family Med Prim Care. 2019; 8(12): 3990–7.

-Mohammed.A. Benign breast disorders in female. Revista de Senología y Patología Mamaria 2022; 35(1) :42-8.

- Singh B, Chakrabarti N. A Clinicopathological Study of Benign Breast Diseases in Females. Med. J. Dr. D.Y. Patil Vidyapeeth.2022; 15(3): 346-51. DOI: 10.4103/mjdrdypu.mjdrdypu_171_20/

- Kumar N, Prasad J. Epidemiology of benign breast lumps, is it changing: a prospective study. Int Surg J 2019;6(2):465-9.

- Yousif Z, Yacoub S. Patterns of Breast Diseases Among Women Attending Breast Diseases Diagnosing Center in Erbil City/Iraq. Glob.J Health Sci. 2018; 10 (4):114-26.

- Khalaf M, Abd Allah I. The Value of Using Grey Scale Ultrasound in the Estimation of Palpable Breast Lumps in a Specialist Breast Clinic in Mosul City of Iraq. (Ann Coll Med Mosul 2021; 43 (1):29- 4.

- Khan.S, Hussain A. Diagnosis Of Fibrocystic Disease Of Breast on Ultrasound. Int. J. Adv. Res. 2019; 7(2): 557-60.

- Kaur D, Garg T, Sachdeva P, Niranjan R. Triple assessment in Diagnosis of Benign Breast Diseases: An Institutional Study. J.med.sci.clin.res.2019 ;7 (10): 588-97.

- Bangaru H, Chandra AS, Gaiki VV.Clinical radiological and pathological assessment of benign breast lumps: our institutional experience. Int Surg J2017; 4(11):3627-32.